Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components.
The report forecast global Biologics and Biosimilars market to grow to reach xx Million USD in 2021 with a CAGR of xx% during the period of 2021-2026.
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively."
The report demonstrates detail coverage of Biologics and Biosimilars industry and main market trends.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
The market research includes historical and forecast data from like demand, application details, price trends, and company shares of the leading Biologics and Biosimilars by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global Biologics and Biosimilars market discussed. Overall, this report covers the historical situation, present status and the future prospects of the global Biologics and Biosimilars market for 2016-2026.
Moreover,the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to over 100 countries and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard,while the online market increase. Fortunately, with the development of vaccine and other effort by global governments and orgnizations, the nagetive impact of COVID-19 is excepted to subside and the global ecnomy is excepted to recover.
Studying and analyzing the impact of Coronavirus COVID-19 on the Biologics and Biosimilars industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
- Monoclonal Antibodies
- Interferon
- Erythropoietin
- Insulin
- Vaccines
- Other
Market Segment by Product Application
- Tumor
- Diabetes
- Cardiovascular
- Hemophilia
- Other
Finally, the report provides detailed profile and data information analysis of leading company.
- Roche
- Eli Lilly
- Sanofi-Aventis
- Amgen
- Novo Nordisk
- AbbVie
- Merck
- Pfizer
- Johnson & Johnson
- Novartis
- Gelgen
- Ganlee
- 3sbio
- Innovent
- Biotech
- Changchun High Tech
- Dong Bao
- CP Guojian
Report Includes:
- xx data tables (appendix tables)
- Overview of global Biologics and Biosimilars market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Biologics and Biosimilars market
- Profiles of major players in the industry, including- Roche,- Eli Lilly,- Sanofi-Aventis,- Amgen,- Novo Nordisk.....
Research Objectives
- 1.To study and analyze the global Biologics and Biosimilars consumption (value & volume) by key regions/countries, product type and application, history data from 2016 to 2020, and forecast to 2026.
- 2.To understand the structure of Biologics and Biosimilars market by identifying its various subsegments.
- 3.Focuses on the key global Biologics and Biosimilars manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
- 4.To analyze the Biologics and Biosimilars with respect to individual growth trends, future prospects, and their contribution to the total market.
- 5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- 6.To project the consumption of Biologics and Biosimilars submarkets, with respect to key regions (along with their respective key countries).
- 7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- 8.To strategically profile the key players and comprehensively analyze their growth strategies.
Global Biologics and Biosimilars Professional Survey Report 2021, Forecast to 2026
Table of Contents
Global Biologics and Biosimilars Professional Survey Report Report 2021, Forecast to 2026
1 Market Study Overview
1.1 Study Objectives
1.2 Biologics and Biosimilars Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Biologics and Biosimilars Segment by Type
2.1.1 Monoclonal Antibodies
2.1.2 Interferon
2.1.3 Erythropoietin
2.1.4 Insulin
2.1.5 Vaccines
2.1.6 Other
2.2 Market Analysis by Application
2.2.1 Tumor
2.2.2 Diabetes
2.2.3 Cardiovascular
2.2.4 Hemophilia
2.2.5 Other
2.3 Global Biologics and Biosimilars Market Comparison by Regions (2016-2026)
2.3.1 Global Biologics and Biosimilars Market Size (2016-2026)
2.3.2 North America Biologics and Biosimilars Status and Prospect (2016-2026)
2.3.3 Europe Biologics and Biosimilars Status and Prospect (2016-2026)
2.3.4 Asia-pacific Biologics and Biosimilars Status and Prospect (2016-2026)
2.3.5 South America Biologics and Biosimilars Status and Prospect (2016-2026)
2.3.6 Middle East & Africa Biologics and Biosimilars Status and Prospect (2016-2026)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Biologics and Biosimilars Industry Impact
2.5.1 Biologics and Biosimilars Business Impact Assessment - Covid-19
2.5.2 Market Trends and Biologics and Biosimilars Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Biologics and Biosimilars Sales and Market Share by Manufacturer (2016-2021)
3.2 Global Biologics and Biosimilars Revenue and Market Share by Manufacturer (2016-2021)
3.3 Global Biologics and Biosimilars Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Biologics and Biosimilars Manufacturer Market Share
3.5 Top 10 Biologics and Biosimilars Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Biologics and Biosimilars Market
3.7 Key Manufacturers Biologics and Biosimilars Product Offered
3.8 Mergers & Acquisitions Planning
4 Analysis of Biologics and Biosimilars Industry Key Manufacturers
4.1 Roche
4.1.1 Company Details
4.1.2 Roche Biologics and Biosimilars Product Introduction, Application and Specification
4.1.3 Roche Biologics and Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.1.4 Main Business Overview
4.1.5 Roche News
4.2 Eli Lilly
4.2.1 Company Details
4.2.2 Eli Lilly Biologics and Biosimilars Product Introduction, Application and Specification
4.2.3 Eli Lilly Biologics and Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.2.4 Main Business Overview
4.2.5 Eli Lilly News
4.3 Sanofi-Aventis
4.3.1 Company Details
4.3.2 Sanofi-Aventis Biologics and Biosimilars Product Introduction, Application and Specification
4.3.3 Sanofi-Aventis Biologics and Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.3.4 Main Business Overview
4.3.5 Sanofi-Aventis News
4.4 Amgen
4.4.1 Company Details
4.4.2 Amgen Biologics and Biosimilars Product Introduction, Application and Specification
4.4.3 Amgen Biologics and Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.4.4 Main Business Overview
4.4.5 Amgen News
4.5 Novo Nordisk
4.5.1 Company Details
4.5.2 Novo Nordisk Biologics and Biosimilars Product Introduction, Application and Specification
4.5.3 Novo Nordisk Biologics and Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.5.4 Main Business Overview
4.5.5 Novo Nordisk News
4.6 AbbVie
4.6.1 Company Details
4.6.2 AbbVie Biologics and Biosimilars Product Introduction, Application and Specification
4.6.3 AbbVie Biologics and Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.6.4 Main Business Overview
4.6.5 AbbVie News
4.7 Merck
4.7.1 Company Details
4.7.2 Merck Biologics and Biosimilars Product Introduction, Application and Specification
4.7.3 Merck Biologics and Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.7.4 Main Business Overview
4.7.5 Merck News
4.8 Pfizer
4.8.1 Company Details
4.8.2 Pfizer Biologics and Biosimilars Product Introduction, Application and Specification
4.8.3 Pfizer Biologics and Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.8.4 Main Business Overview
4.8.5 Pfizer News
4.9 Johnson & Johnson
4.9.1 Company Details
4.9.2 Johnson & Johnson Biologics and Biosimilars Product Introduction, Application and Specification
4.9.3 Johnson & Johnson Biologics and Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.9.4 Main Business Overview
4.9.5 Johnson & Johnson News
4.10 Novartis
4.10.1 Company Details
4.10.2 Novartis Biologics and Biosimilars Product Introduction, Application and Specification
4.10.3 Novartis Biologics and Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.10.4 Main Business Overview
4.10.5 Novartis News
4.11 Gelgen
4.11.1 Company Details
4.11.2 Gelgen Biologics and Biosimilars Product Introduction, Application and Specification
4.11.3 Gelgen Biologics and Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.11.4 Main Business Overview
4.11.5 Gelgen News
4.12 Ganlee
4.12.1 Company Details
4.12.2 Ganlee Biologics and Biosimilars Product Introduction, Application and Specification
4.12.3 Ganlee Biologics and Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.12.4 Main Business Overview
4.12.5 Ganlee News
4.13 3sbio
4.13.1 Company Details
4.13.2 3sbio Biologics and Biosimilars Product Introduction, Application and Specification
4.13.3 3sbio Biologics and Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.13.4 Main Business Overview
4.13.5 3sbio News
4.14 Innovent
4.14.1 Company Details
4.14.2 Innovent Biologics and Biosimilars Product Introduction, Application and Specification
4.14.3 Innovent Biologics and Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.14.4 Main Business Overview
4.14.5 Innovent News
4.15 Biotech
4.15.1 Company Details
4.15.2 Biotech Biologics and Biosimilars Product Introduction, Application and Specification
4.15.3 Biotech Biologics and Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.15.4 Main Business Overview
4.15.5 Biotech News
4.16 Changchun High Tech
4.16.1 Company Details
4.16.2 Changchun High Tech Biologics and Biosimilars Product Introduction, Application and Specification
4.16.3 Changchun High Tech Biologics and Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.16.4 Main Business Overview
4.16.5 Changchun High Tech News
4.17 Dong Bao
4.17.1 Company Details
4.17.2 Dong Bao Biologics and Biosimilars Product Introduction, Application and Specification
4.17.3 Dong Bao Biologics and Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.17.4 Main Business Overview
4.17.5 Dong Bao News
4.18 CP Guojian
4.18.1 Company Details
4.18.2 CP Guojian Biologics and Biosimilars Product Introduction, Application and Specification
4.18.3 CP Guojian Biologics and Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.18.4 Main Business Overview
4.18.5 CP Guojian News
5 Global Biologics and Biosimilars Sales Categorized by Regions
5.1 Global Biologics and Biosimilars Revenue, Sales and Market Share by Regions
5.1.1 Global Biologics and Biosimilars Sales and Market Share by Regions (2016-2021)
5.1.2 Global Biologics and Biosimilars Revenue and Market Share by Regions (2016-2021)
5.2 North America Biologics and Biosimilars Sales and Growth Rate (2016-2021)
5.3 Europe Biologics and Biosimilars Sales and Growth Rate (2016-2021)
5.4 Asia-pacific Biologics and Biosimilars Sales and Growth Rate (2016-2021)
5.5 South America Biologics and Biosimilars Sales and Growth Rate (2016-2021)
5.6 Middle East & Africa Biologics and Biosimilars Sales and Growth Rate (2016-2021)
6 North America Biologics and Biosimilars Market Size Categorized by Countries
6.1 North America Biologics and Biosimilars Sales, Revenue and Market Share by Countries
6.1.1 North America Biologics and Biosimilars Sales (Volume) by Countries (2016-2021)
6.1.2 North America Biologics and Biosimilars Revenue by Countries (2016-2021)
6.1.3 United States Biologics and Biosimilars Sales and Growth Rate (2016-2021)
6.1.4 Canada Biologics and Biosimilars Sales and Growth Rate (2016-2021)
6.1.5 Mexico Biologics and Biosimilars Sales and Growth Rate (2016-2021)
6.2 North America Biologics and Biosimilars Revenue (Value) by Manufacturers
6.3 North America Biologics and Biosimilars Sales and Market Share by Type (2016-2021)
6.4 North America Biologics and Biosimilars Sales Market Share by Application (2016-2021)
7 Europe Biologics and Biosimilars Market Size Categorized by Countries
7.1 Europe Biologics and Biosimilars Sales, Revenue and Market Share by Countries
7.1.1 Europe Biologics and Biosimilars Sales (Volume) by Countries (2016-2021)
7.1.2 Europe Biologics and Biosimilars Revenue by Countries (2016-2021)
7.1.3 Germany Biologics and Biosimilars Sales and Growth Rate (2016-2021)
7.1.4 UK Biologics and Biosimilars Sales and Growth Rate (2016-2021)
7.1.5 France Biologics and Biosimilars Sales and Growth Rate (2016-2021)
7.1.6 Russia Biologics and Biosimilars Sales and Growth Rate (2016-2021)
7.1.7 Italy Biologics and Biosimilars Sales and Growth Rate (2016-2021)
7.1.8 Spain Biologics and Biosimilars Sales and Growth Rate (2016-2021)
7.2 Europe Biologics and Biosimilars Revenue (Value) by Manufacturers
7.3 Europe Biologics and Biosimilars Sales and Market Share by Type (2016-2021)
7.4 Europe Biologics and Biosimilars Sales Market Share by Application (2016-2021)
8 Asia-Pacific Biologics and Biosimilars Market Size Categorized by Countries
8.1 Asia-pacific Biologics and Biosimilars Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Biologics and Biosimilars Sales (Volume) by Countries (2016-2021)
8.1.2 Asia-pacific Biologics and Biosimilars Revenue by Countries (2016-2021)
8.1.3 China Biologics and Biosimilars Sales and Growth Rate (2016-2021)
8.1.4 South Korea Biologics and Biosimilars Sales and Growth Rate (2016-2021)
8.1.5 Japan Biologics and Biosimilars Sales and Growth Rate (2016-2021)
8.1.6 Australia Biologics and Biosimilars Sales and Growth Rate (2016-2021)
8.1.7 India Biologics and Biosimilars Sales and Growth Rate (2016-2021)
8.1.8 Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2016-2021)
8.2 Asia-pacific Biologics and Biosimilars Revenue (Value) by Manufacturers
8.3 Asia-pacific Biologics and Biosimilars Sales and Market Share by Type (2016-2021)
8.4 Asia-pacific Biologics and Biosimilars Sales Market Share by Application (2016-2021)
9 South America Biologics and Biosimilars Market Size Categorized by Countries
9.1 South America Biologics and Biosimilars Sales, Revenue and Market Share by Countries
9.1.1 South America Biologics and Biosimilars Sales (Volume) by Countries (2016-2021)
9.1.2 South America Biologics and Biosimilars Revenue by Countries (2016-2021)
9.1.3 Brazil Biologics and Biosimilars Sales and Growth Rate (2016-2021)
9.2 South America Biologics and Biosimilars Sales and Market Share by Type (2016-2021)
9.3 South America Biologics and Biosimilars Sales Market Share by Application (2016-2021)
10 Middle East and Africa Biologics and Biosimilars Market Size Categorized by Countries
10.1 Middle East and Africa Biologics and Biosimilars Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Biologics and Biosimilars Sales (Volume) by Countries (2016-2021)
10.1.2 Middle East and Africa Biologics and Biosimilars Revenue by Countries (2016-2021)
10.1.3 GCC Countries Biologics and Biosimilars Sales and Growth Rate (2016-2021)
10.1.4 Turkey Biologics and Biosimilars Sales and Growth Rate (2016-2021)
10.1.5 Egypt Biologics and Biosimilars Sales and Growth Rate (2016-2021)
10.1.6 South America Biologics and Biosimilars Sales and Growth Rate (2016-2021)
10.2 Middle East and Africa Biologics and Biosimilars Sales and Market Share by Type
10.3 Middle East and Africa Biologics and Biosimilars Sales Market Share by Application (2016-2021)
11 Global Biologics and Biosimilars Market Segment by Type
11.1 Global Biologics and Biosimilars Revenue, Sales and Market Share by Type (2016-2021)
11.1.1 Global Biologics and Biosimilars Sales and Market Share by Type (2016-2021)
11.1.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2016-2021)
11.2 Monoclonal Antibodies Sales Growth Rate and Price
11.2.1 Global Monoclonal Antibodies Sales Growth Rate (2016-2021)
11.2.2 Global Monoclonal Antibodies Price (2016-2021)
11.3 Interferon Sales Growth Rate and Price
11.3.1 Global Interferon Sales Growth Rate (2016-2021)
11.3.2 Global Interferon Price (2016-2021)
11.4 Erythropoietin Sales Growth Rate and Price
11.4.1 Global Erythropoietin Sales Growth Rate (2016-2021)
11.4.2 Global Erythropoietin Price (2016-2021)
11.5.1 Global Insulin Sales Growth Rate (2016-2021)
11.5.2 Global Insulin Price (2016-2021)
11.6 Vaccines Sales Growth Rate and Price
11.6.1 Global Vaccines Sales Growth Rate (2016-2021)
11.6.2 Global Vaccines Price (2016-2021)
11.7 Other Sales Growth Rate and Price
11.7.1 Global Other Sales Growth Rate (2016-2021)
11.7.2 Global Other Price (2016-2021)
12 Global Biologics and Biosimilars Market Segment by Application
12.1 Global Biologics and Biosimilars Sales Market Share by Application (2016-2021)
12.2 Tumor Sales Growth Rate (2016-2021)
12.3 Diabetes Sales Growth Rate (2016-2021)
12.4 Cardiovascular Sales Growth Rate (2016-2021)
12.5 Hemophilia Sales Growth Rate (2016-2021)
13 Global Biologics and Biosimilars Market Forecast
13.1 Global Biologics and Biosimilars Revenue, Sales and Growth Rate (2021-2026)
13.2 Biologics and Biosimilars Market Forecast by Regions (2021-2026)
13.2.1 North America Biologics and Biosimilars Market Forecast (2021-2026)
13.2.2 Europe Biologics and Biosimilars Market Forecast (2021-2026)
13.2.3 Asia-Pacific Biologics and Biosimilars Market Forecast (2021-2026)
13.2.4 South America Biologics and Biosimilars Market Forecast (2021-2026)
13.2.5 Middle East & Africa Biologics and Biosimilars Market Forecast (2021-2026)
13.3 Biologics and Biosimilars Market Forecast by Type (2021-2026)
13.3.1 Global Biologics and Biosimilars Sales Forecast by Type (2021-2026)
13.3.2 Global Biologics and Biosimilars Market Share Forecast by Type (2021-2026)
13.4 Biologics and Biosimilars Market Forecast by Application (2021-2026)
13.4.1 Global Biologics and Biosimilars Sales Forecast by Application (2021-2026)
13.4.2 Global Biologics and Biosimilars Market Share Forecast by Application (2021-2026)
14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis
15 Biologics and Biosimilars Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Biologics and Biosimilars Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers
List of Tables and Figures
Figure Product Picture Biologics and Biosimilars
Figure Market Concentration Ratio and Market Maturity Analysis of Biologics and Biosimilars
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Biologics and Biosimilars Market Size by Type
Figure Global Market Share of Biologics and Biosimilars by Type in 2020
Figure Monoclonal Antibodies Picture
Figure Interferon Picture
Figure Erythropoietin Picture
Figure Insulin Picture
Figure Vaccines Picture
Figure Other Picture
Table Global Biologics and Biosimilars Market Size (Volume) by Application
Figure Tumor Picture
Figure Diabetes Picture
Figure Cardiovascular Picture
Figure Hemophilia Picture
Figure Other Picture
Table Global Biologics and Biosimilars Comparison by Regions (M USD) 2016-2026
Figure Global Biologics and Biosimilars Market Size (Million US$) (2016-2026)
Figure North America Biologics and Biosimilars Revenue (Million US$) Growth Rate (2016-2026)
Figure Europe Biologics and Biosimilars Revenue (Million US$) Growth Rate (2016-2026)
Figure Asia-pacific Biologics and Biosimilars Revenue (Million US$) Growth Rate (2016-2026)
Figure South America Biologics and Biosimilars Revenue (Million US$) Growth Rate (2016-2026)
Figure Middle East & Africa Biologics and Biosimilars Revenue (Million US$) Growth Rate (2016-2026)
Table Business Impact Assessment - Covid-19
Table Market Trends and Biologics and Biosimilars Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Biologics and Biosimilars Sales by Manufacturer (2016-2021)
Figure Global Biologics and Biosimilars Sales Market Share by Manufacturer in 2020
Table Global Biologics and Biosimilars Revenue by Manufacturer (2016-2021)
Figure Global Biologics and Biosimilars Revenue Market Share by Manufacturer in 2020
Table Global Biologics and Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Biologics and Biosimilars Manufacturer (Revenue) Market Share in 2020
Figure Top 10 Biologics and Biosimilars Manufacturer (Revenue) Market Share in 2020
Table Date of Key Manufacturers Enter into Biologics and Biosimilars Market
Table Key Manufacturers Biologics and Biosimilars Product Type
Table Mergers & Acquisitions Planning
Table Roche Company Profile
Table Biologics and Biosimilars Product Introduction, Application and Specification of Roche
Table Biologics and Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Roche 2016-2021
Table Roche Main Business
Table Roche Recent Development
Table Eli Lilly Company Profile
Table Biologics and Biosimilars Product Introduction, Application and Specification of Eli Lilly
Table Biologics and Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Eli Lilly 2016-2021
Table Eli Lilly Main Business
Table Eli Lilly Recent Development
Table Sanofi-Aventis Company Profile
Table Biologics and Biosimilars Product Introduction, Application and Specification of Sanofi-Aventis
Table Biologics and Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Sanofi-Aventis 2016-2021
Table Sanofi-Aventis Main Business
Table Sanofi-Aventis Recent Development
Table Amgen Company Profile
Table Biologics and Biosimilars Product Introduction, Application and Specification of Amgen
Table Biologics and Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Amgen 2016-2021
Table Amgen Main Business
Table Amgen Recent Development
Table Novo Nordisk Company Profile
Table Biologics and Biosimilars Product Introduction, Application and Specification of Novo Nordisk
Table Biologics and Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Novo Nordisk 2016-2021
Table Novo Nordisk Main Business
Table Novo Nordisk Recent Development
Table AbbVie Company Profile
Table Biologics and Biosimilars Product Introduction, Application and Specification of AbbVie
Table Biologics and Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of AbbVie 2016-2021
Table AbbVie Main Business
Table AbbVie Recent Development
Table Merck Company Profile
Table Biologics and Biosimilars Product Introduction, Application and Specification of Merck
Table Biologics and Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Merck 2016-2021
Table Merck Main Business
Table Merck Recent Development
Table Pfizer Company Profile
Table Biologics and Biosimilars Product Introduction, Application and Specification of Pfizer
Table Biologics and Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2016-2021
Table Pfizer Main Business
Table Pfizer Recent Development
Table Johnson & Johnson Company Profile
Table Biologics and Biosimilars Product Introduction, Application and Specification of Johnson & Johnson
Table Biologics and Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Johnson & Johnson 2016-2021
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Table Novartis Company Profile
Table Biologics and Biosimilars Product Introduction, Application and Specification of Novartis
Table Biologics and Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Novartis 2016-2021
Table Novartis Main Business
Table Novartis Recent Development
Table Gelgen Company Profile
Table Biologics and Biosimilars Product Introduction, Application and Specification of Gelgen
Table Biologics and Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Gelgen 2016-2021
Table Gelgen Main Business
Table Gelgen Recent Development
Table Ganlee Company Profile
Table Biologics and Biosimilars Product Introduction, Application and Specification of Ganlee
Table Biologics and Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Ganlee 2016-2021
Table Ganlee Main Business
Table Ganlee Recent Development
Table 3sbio Company Profile
Table Biologics and Biosimilars Product Introduction, Application and Specification of 3sbio
Table Biologics and Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of 3sbio 2016-2021
Table 3sbio Main Business
Table 3sbio Recent Development
Table Innovent Company Profile
Table Biologics and Biosimilars Product Introduction, Application and Specification of Innovent
Table Biologics and Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Innovent 2016-2021
Table Innovent Main Business
Table Innovent Recent Development
Table Biotech Company Profile
Table Biologics and Biosimilars Product Introduction, Application and Specification of Biotech
Table Biologics and Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Biotech 2016-2021
Table Biotech Main Business
Table Biotech Recent Development
Table Changchun High Tech Company Profile
Table Biologics and Biosimilars Product Introduction, Application and Specification of Changchun High Tech
Table Biologics and Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Changchun High Tech 2016-2021
Table Changchun High Tech Main Business
Table Changchun High Tech Recent Development
Table Dong Bao Company Profile
Table Biologics and Biosimilars Product Introduction, Application and Specification of Dong Bao
Table Biologics and Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Dong Bao 2016-2021
Table Dong Bao Main Business
Table Dong Bao Recent Development
Table CP Guojian Company Profile
Table Biologics and Biosimilars Product Introduction, Application and Specification of CP Guojian
Table Biologics and Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of CP Guojian 2016-2021
Table CP Guojian Main Business
Table CP Guojian Recent Development
Figure Global Biologics and Biosimilars Sales and Growth Rate (2016-2021)
Figure Global Biologics and Biosimilars Revenue and Growth Rate (2016-2021)
Table Global Biologics and Biosimilars Sales by Regions (2016-2021)
Figure Global Biologics and Biosimilars Sales Market Share by Regions in 2020
Table Global Biologics and Biosimilars Revenue by Regions (2016-2021)
Figure Global Biologics and Biosimilars Revenue Market Share by Regions in 2020
Figure North America Biologics and Biosimilars Sales and Growth Rate (2016-2021)
Figure Europe Biologics and Biosimilars Sales and Growth Rate (2016-2021)
Figure Asia-pacific Biologics and Biosimilars Sales and Growth Rate (2016-2021)
Figure South America Biologics and Biosimilars Sales and Growth Rate (2016-2021)
Figure Middle East & Africa Biologics and Biosimilars Sales and Growth Rate (2016-2021)
Figure North America Biologics and Biosimilars Revenue and Growth Rate (2016-2021)
Table North America Biologics and Biosimilars Sales (Volume) by Countries (2016-2021)
Table North America Biologics and Biosimilars Sales Market Share by Countries (2016-2021)
Figure North America Biologics and Biosimilars Sales Market Share by Countries in 2020
Table North America Biologics and Biosimilars Revenue by Countries (2016-2021)
Table North America Biologics and Biosimilars Revenue Market Share by Countries (2016-2021)
Figure North America Biologics and Biosimilars Revenue Market Share by Countries in 2020
Figure United States Biologics and Biosimilars Sales and Growth Rate (2016-2021)
Figure Canada Biologics and Biosimilars Sales and Growth Rate (2016-2021)
Figure Mexico Biologics and Biosimilars Sales and Growth Rate (2016-2021)
Table North America Biologics and Biosimilars Revenue by Manufacturer (2020)
Figure North America Biologics and Biosimilars Revenue Market Share by Manufacturer in 2020
Table North America Biologics and Biosimilars Sales by Type (2016-2021)
Table North America Biologics and Biosimilars Sales Share by Type (2016-2021)
Table North America Biologics and Biosimilars Sales by Application (2016-2021)
Table North America Biologics and Biosimilars Sales Share by Application (2016-2021)
Figure Europe Biologics and Biosimilars Revenue and Growth Rate (2016-2021)
Table Europe Biologics and Biosimilars Sales (Volume) by Countries (2016-2021)
Table Europe Biologics and Biosimilars Sales Market Share by Countries (2016-2021)
Figure Europe Biologics and Biosimilars Sales Market Share by Countries in 2020
Table Europe Biologics and Biosimilars Revenue by Countries (2016-2021)
Table Europe Biologics and Biosimilars Revenue Market Share by Countries (2016-2021)
Figure Europe Biologics and Biosimilars Revenue Market Share by Countries in 2020
Figure Germany Biologics and Biosimilars Sales and Growth Rate (2016-2021)
Figure UK Biologics and Biosimilars Sales and Growth Rate (2016-2021)
Figure France Biologics and Biosimilars Sales and Growth Rate (2016-2021)
Figure Russia Biologics and Biosimilars Sales and Growth Rate (2016-2021)
Figure Italy Biologics and Biosimilars Sales and Growth Rate (2016-2021)
Figure Spain Biologics and Biosimilars Sales and Growth Rate (2016-2021)
Table Europe Biologics and Biosimilars Revenue by Manufacturer (2020)
Figure Europe Biologics and Biosimilars Revenue Market Share by Manufacturer in 2020
Table Europe Biologics and Biosimilars Sales by Type (2016-2021)
Table Europe Biologics and Biosimilars Sales Share by Type (2016-2021)
Table Europe Biologics and Biosimilars Sales by Application (2016-2021)
Table Europe Biologics and Biosimilars Sales Share by Application (2016-2021)
Figure Asia-pacific Biologics and Biosimilars Revenue and Growth Rate (2016-2021)
Table Asia-pacific Biologics and Biosimilars Sales (Volume) by Countries (2016-2021)
Table Asia-pacific Biologics and Biosimilars Sales Market Share by Countries (2016-2021)
Figure Asia-pacific Biologics and Biosimilars Sales Market Share by Countries in 2020
Table Asia-pacific Biologics and Biosimilars Revenue by Countries (2016-2021)
Table Asia-pacific Biologics and Biosimilars Revenue Market Share by Countries (2016-2021)
Figure Asia-pacific Biologics and Biosimilars Revenue Market Share by Countries in 2020
Figure China Biologics and Biosimilars Sales and Growth Rate (2016-2021)
Figure South Korea Biologics and Biosimilars Sales and Growth Rate (2016-2021)
Figure Japan Biologics and Biosimilars Sales and Growth Rate (2016-2021)
Figure Australia Biologics and Biosimilars Sales and Growth Rate (2016-2021)
Figure India Biologics and Biosimilars Sales and Growth Rate (2016-2021)
Figure Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2016-2021)
Table Asia-pacific Biologics and Biosimilars Revenue by Manufacturer (2020)
Figure Asia-pacific Biologics and Biosimilars Revenue Market Share by Manufacturer in 2020
Table Asia-pacific Biologics and Biosimilars Sales by Type (2016-2021)
Table Asia-pacific Biologics and Biosimilars Sales Share by Type (2016-2021)
Table Asia-pacific Biologics and Biosimilars Sales by Application (2016-2021)
Table Asia-pacific Biologics and Biosimilars Sales Share by Application (2016-2021)
Figure South America Biologics and Biosimilars Revenue and Growth Rate (2016-2021)
Table South America Biologics and Biosimilars Sales (Volume) by Countries (2016-2021)
Table South America Biologics and Biosimilars Sales Market Share by Countries (2016-2021)
Figure South America Biologics and Biosimilars Sales Market Share by Countries in 2019
Table South America Biologics and Biosimilars Revenue by Countries (2016-2021)
Table South America Biologics and Biosimilars Revenue Market Share by Countries (2016-2021)
Figure South America Biologics and Biosimilars Revenue Market Share by Countries in 2019
Figure Brazil Biologics and Biosimilars Sales and Growth Rate (2016-2021)
Table South America Biologics and Biosimilars Sales by Type (2016-2021)
Table South America Biologics and Biosimilars Sales Share by Type (2016-2021)
Table South America Biologics and Biosimilars Revenue by Type (2016-2021)
Table South America Biologics and Bi
Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 147
According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period.
The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......
Global Biosimilar Drug Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 94
According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......
Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 147
According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period.
Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......
Global Biosimilars Market Research Report 2023, Forecast to 2028
Published: 27-Dec-2023 Price: US 2680 Onwards Pages: 167
A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine').
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
Global Biosimilars Professional Survey Report 2023, Forecast to 2028
Published: 27-Dec-2023 Price: US 3280 Onwards Pages: 133
A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine').
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 07-Dec-2023 Price: US 3380 Onwards Pages: 106
Market Overview of Global Biosimilars market:
According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years.
A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......
Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028
Published: 24-Nov-2023 Price: US 3280 Onwards Pages: 134
Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028
Published: 24-Nov-2023 Price: US 2680 Onwards Pages: 160
Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 16-Nov-2023 Price: US 3380 Onwards Pages: 103
Market Overview of Global Biosimilar Monoclonal Antibodies market:
According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
